By David Mittleman

Image from

Dangerous Stent Remains Available on Market

The Wingspan intracranial stent, manufactured by Stryker Neurovascular and used in the case of Intracranial Atherosclerosis, was approved in 2005 but has come under fire in recent days after the release of several studies. One of those studies, conducted by the National Institutes of Health, included 451 patients and involved a two groups of participants: one group received aggressive medical therapy and the other group received the same medical therapy in addition to the stent. That trial was prematurely cut short because of a shocking number of strokes and …read more